C.D.C. Panel Keeps Pause on Use of J & J Vaccine, Weighing Risks

An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension ’s effect on global needs for a one-shot, easy-to-ship vaccine.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Blood Clots Vaccination and Immunization Coronavirus (2019-nCoV) Women and Girls Advisory Committee on Immunization Practices AstraZeneca PLC Centers for Disease Control and Prevention Johnson & Food and Drug Administration your-feed-h Source Type: news